OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine (vol 78, pg 589, 2018)

被引：2
|
作者：
Frampton, James E. [1 ]
Silberstein, Stephen [2 ]
机构：
[1] Springer, Private Bag 65901, Auckland 0754, New Zealand
[2] Jefferson Headache Ctr, Philadelphia, PA USA
来源：
DRUGS | 2018年 / 78卷 / 06期
关键词：
D O I：
10.1007/s40265-018-0906-6
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The article OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine, written by James E. Frampton and Stephen Silberstein, was originally published Online First without open access. After publication in volume 78, issue 5, pages 589–600 [funder] requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by [funder]. Further details may be found at [MedEngine webpage link].
引用
收藏
页码：715 / 715
页数：1
相关论文
共 50 条
  • [41] Direct Measurement of Scientific Giftedness (vol 40, pg 78, 2018)
    Sternberg, Robert J.
    ROEPER REVIEW-A JOURNAL ON GIFTED EDUCATION, 2018, 40 (03): : 212 - 212
  • [42] Fremanezumab: First Global Approval (vol 78, pg 1829, 2018)
    Hoy, Sheridan M.
    DRUGS, 2019, 79 (05) : 585 - 585
  • [43] Elagolix: First Global Approval (vol 78, pg 1501, 2018)
    Lamb, Yvette N.
    DRUGS, 2018, 78 (17) : 1855 - 1855
  • [44] Ibalizumab: First Global Approval(vol 78, pg 781, 2018)
    Markham, Anthony
    DRUGS, 2018, 78 (08) : 859 - 859
  • [45] Ivosidenib: First Global Approval (vol 78, pg 1509, 2018)
    Dhillon, Sohita
    DRUGS, 2019, 79 (01) : 107 - 107
  • [46] Anlotinib: First Global Approval (vol 78, pg 1057, 2018)
    Syed, Yahiya Y.
    DRUGS, 2018, 78 (12) : 1287 - 1287
  • [47] A Retrospective Analysis to Evaluate the Response of the Addition of Erenumab to OnabotulinumtoxinA for the Prevention of Intractable Chronic Migraine Without Aura
    Armanious, M.
    Jimenez-Sanders, R.
    HEADACHE, 2019, 59 : 166 - 167
  • [48] Pericranial Muscle Stiffness, Pain Thresholds, and Tenderness during a Treatment Cycle of OnabotulinumtoxinA for Chronic Migraine Prevention
    Dalby, Sebastian Worsaae
    Hvedstrup, Jeppe
    Carlsen, Louise Ninett
    Ashina, Sait
    Bendtsen, Lars
    Schytz, Henrik Winther
    DIAGNOSTICS, 2024, 14 (03)
  • [49] The impact of fremanezumab on medication overuse in patients with chronic migraine (vol 19, pg P12, 2018)
    Silberstein, Stephen D.
    Ashina, Sait
    Katsarava, Zaza
    Bibeau, Kristen
    Seminerio, Michael J.
    Harlow, Danielle E.
    Cohen, Joshua M.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [50] Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache (vol 80, pg 893, 2020)
    Scott, Lesley J.
    DRUGS, 2020, 80 (13) : 1379 - 1379
12345